Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 06, 2019

SELL
$1.01 - $2.78 $368,045 - $1.01 Million
-364,401 Closed
0 $0
Q3 2018

Oct 16, 2018

BUY
$1.72 - $2.71 $343,649 - $541,447
199,796 Added 121.38%
364,401 $988,000
Q2 2018

Jul 17, 2018

BUY
$1.72 - $2.26 $283,120 - $372,007
164,605 New
164,605 $314,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.